Drug Profile
CA(1-8)M(1-18)
Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 15 Nov 1999 New profile
- 15 Nov 1999 Preclinical development for Bacterial infections in Spain (Unknown route)